Hydroxychloroquine for Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: Challenges to Trial Conduct During the Global Pandemic
Clin Infect Dis
.
2021 Jun 1;72(11):e844-e847.
doi: 10.1093/cid/ciaa1707.
Author
Jason D Goldman
1
2
Affiliations
1
Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, Washington, USA.
2
Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington, USA.
PMID:
33159196
PMCID:
PMC7717228
DOI:
10.1093/cid/ciaa1707
No abstract available
Keywords:
COVID-19; SARS-CoV-2; Twitter; hydroxychloroquine; pandemic.
Publication types
Editorial
Comment
MeSH terms
COVID-19 Drug Treatment*
Health Personnel
Humans
Hydroxychloroquine / therapeutic use
Pandemics
Pre-Exposure Prophylaxis*
SARS-CoV-2
Substances
Hydroxychloroquine